The clinical data world has been promised transformation before. With advancements like eSource, risk-based monitoring, and ...
Advarra funds PRIM&R AI ethics curriculum for research oversight. IRBs gain guidance on algorithm governance and AI tool ...
The NEJM just reframed reproducibility in biomedical science, and every clinical trial sponsor still designing for repetition ...
Neurology trial sites take 167 days to activate on average, causing enrollment delays and pushing Phase III programs millions over budget.
Joint Commission awards UPMC's Genomic Surveillance Program for detecting hospital bacterial transmission events missed by conventional infection surveillance m ...
A $3.4M grant funds research into how perimenopause hormonal changes may increase Alzheimer's risk in women, who face double ...
Only 12% of ~4,000 clinical prediction model studies share code, per Nature Medicine. FDA and NIH mandates exist, but ...
COA Integration With EDC is critical for CNS trials: disconnected systems trigger weeks of reconciliation work at database ...
Clinical data teams now prioritize AI validation and human oversight in regulatory workflows, following FDA guidance on ...
Tenax pauses LEVEL-2 enrollment to refine TNX-103 patient selection after the initial trial missed its primary walking ...
Phase III trial of cadonilimab begins in perioperative colon cancer, testing dual PD-1/CTLA-4 blockade in MSI-H/dMMR patients ...
SYCUME met its Phase 3 primary endpoint for inactive thyroid eye disease, showing significant proptosis reduction versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results